biotech, you know as well as I do that planning an AD trial takes many months of work. No one is going to plan to use LymPro in their trial until that product is actually available for use in the trial, which was only a short time ago. Based on the feedback the company received from researchers and Key Opinion Leaders prior to the commercial launch, I remain confident that LymPro is currently included in the planning stages of many upcoming drug trials. When those are finalized and the contracts are signed, the company will make the appropriate announcements, and not before.

Some have so little faith and patience that they quickly assume that with only one small trial announced so far, that LymPro is a dud and no one is interested. Since many of you boast about critical thinking and being objective, where's the critical thinking when it comes to the AD trial planning time. If one considers that, then the calendar math would indicate there could be a multitude of trial announcements involving LymPro to be revealed in the coming months.

Have a little patience. If we get to June and we still don't have any additional trials using LymPro, I will start to be concerned that perhaps things aren't working out as we expected.